Skip to main content
. 2016 Sep 28;7:331. doi: 10.3389/fphar.2016.00331

Table 3.

Adverse events of axitinib in our study population.

AE Axitinib titration
All grades (n = 62) N (%) ≥Grade 3 (n = 62) All grades (n = 15) N (%) ≥Grade 3 (n = 15)
Hematologic 2 (3.3)
Hypertension 11 (18) 3 (4.9) 2 (13.3) 1 (6.7)
Gastro-intestinal 9 (14.5) 3 (4.8) 2 (13.3)
Hypothyroidism 10 (16.1) 3(20)
Fatig 11 (17.7) 5(8.1) 3(20) 1 (6.7)
Hepatic 1 (1.6)
Hand–foot syndrome 4 (6.5) 1 (1.6) 2(13.3) 1(6.7)
Dysphonia 2(13.3)